Navigation Links
Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors
Date:8/12/2009

CHAPEL HILL, N.C., Aug. 12 /PRNewswire/ -- Cempra Pharmaceuticals today announced the appointment of John H. Johnson, Chief Executive Officer of ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to the company's Board of Directors. Mr. Johnson brings more than 25 years of biopharmaceutical executive and operational management experience, including leadership of successful anti-infective businesses and numerous flagship pharmaceutical products, to his role as an independent member of the Board.

"I've been closely tied to the antibacterial and public health product markets throughout my career in the biopharmaceutical industry, and Cempra's clinical-stage anti-infective programs address an absolutely critical market need for safe, potent antibiotics," said Mr. Johnson. "Cempra is at a turning point in the company's development of its two lead compounds, as both are poised to advance into later stage clinical trials. I look forward to working with Cempra's other Board members and management to enable the success of these much-needed drugs."

Cempra's lead macrolide, CEM-101, will soon enter a Phase 2 clinical trial for moderate to moderately severe community-acquired bacterial pneumonia. Cempra has also initiated an adaptive design Phase 2/3 trial in acute bacterial skin structure infections for CEM-102, an antibiotic with an established record of treating staphylococcal infections, including methicillin-resistant Staphylococcus aureus (MRSA). Cempra recently completed a $46 million Series C financing that will fund the further development of these compounds.

"John's respected reputation, deep knowledge of the antibacterial market and strong business acumen makes him an extremely well-positioned, highly-valued addition to our Board of Directors," said Prabhavathi Fernandes, President and CEO, Cempra Pharmaceuticals. "Following a ve
'/>"/>

SOURCE Cempra Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
3. OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011
4. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
5. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
6. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
7. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
8. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
9. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. ADVENTRX Pharmaceuticals Announces Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... GA (PRWEB) May 17, 2013 Dr. ... Gynecology, and Women’s Health at the Albert Einstein College ... Oncology at the Montefiore Medical Center. He is ... Cancer Center and leads the Einstein Breast Cancer Working ... on translational breast cancer research. He also serves as ...
(Date:5/17/2013)... Organ transplant rejection occurs when the transplant recipient,s immune ... attacks it. It was previously thought that T cells, ... activated by molecules known as chemokines in order to ... the Journal of Clinical Investigation , Fadi Lakkis ... to demonstrate that chemokine stimulation of T cells is ...
(Date:5/17/2013)... world-leading provider of scientific, technical and medical information products ... study in Reproductive BioMedicine Online ... an abnormal chromosomal composition can be identified by the ... classifying the risk of genetic abnormality without a biopsy. ... a retrospective study, using their predictive model to assess ...
(Date:5/17/2013)... PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability ,     New ... insect pressures , Syngenta unveiled ... celebration today at the company’s RTP Innovation Center. The ... allows company researchers to simulate any agricultural climate and ...
Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... 22 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced ... BIOCOM Investor Conference on October 28, 2008 at 2:00 ... Regency Hotel in La,Jolla, California. Jack Lief, Arena,s President ... of the company, including its,clinical development and discovery programs., ...
... GENZ ) has announced findings from an ... treatments with Synvisc and Hyalgan in patients with,osteoarthritis ... Synvisc,provided longer knee pain relief and a higher ... orthopaedic surgeon Raghu Raman and a team of ...
... following Webcast:, What: Transgenomic Inc. Third Quarter ... Conference Call, When: Wednesday, October 29, 2008 ... How: Live over the Internet -- Simply log ... address above., Contact: Investor Relations, 402-452-5400, ...
Cached Biology Technology:Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 2Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 3Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee 2Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee 3Webcast Alert: Transgenomic Inc. Announces Third Quarter 2008 Earnings Release Conference Call Webcast 2
(Date:5/18/2013)... FL (May 18, 2013) An increasing number ... require interventions to resolve, according to research presented ... one study targeting obesity, researchers at the Cleveland ... a unique pattern of exhaled breath compared to ... volatile organic compound levels that can be correlated ...
(Date:5/17/2013)... provide the white noise of the South, but the night ... Southern air hangs heavy from the humidity and the sounds ... 140 species of frogs, toads and salamanders, is the center ... and swamps are the auditorium for their symphonic choruses, the ... Initiative, or ARMI, have front-row seats. , Amphibians, ...
(Date:5/17/2013)... Atlanta residents of all ages will celebrate the ... impact on our daily lives during the inaugural ... engineers and educators from local museums, corporations, K-12 ... than 40 different events for children and adults ... http://atlantasciencefestival.org . , The annual Atlanta ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4First Atlanta Science Festival set for 2014 2
... clear agenda when it comes to selecting a mating partner: ... large females, they are likely to have more and bigger ... and Tony Wilson from the Zoological Museum at the University ... been published online in Springer,s journal Behavioral Ecology and ...
... 2009 Standards Division Guidelines" is the subject of ... the Journal of Vascular and Interventional Radiology ... allied health professionals dedicated to improving public health ... interventionsprovides a unique collection of new (such as ...
... Stone of bacterial communication may have been found. Although ... idea about what,s going on in their neighborhood and communicate ... from their surrounding environment. Even though there are millions of ... the world around them, Duke University bioengineers believe they have ...
Cached Biology News:Male seahorses like big mates 2Journal of Vascular and Interventional Radiology: New patient radiation safety guidelines 2Journal of Vascular and Interventional Radiology: New patient radiation safety guidelines 3Finding the constant in bacterial communication 2Finding the constant in bacterial communication 3
2'-Fluorine-CTP (2'-F-CTP) is readily incorporated into transcripts by T7 and SP6 R&DNA™ Polymerase and is available separately....
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates...
Human BMP 2 Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
... lowest priced, full ring small animal imaging ... the microPET R4 low retail price, it ... categories; count rate performance, energy resolution, timing ... dedicated small animal PET (Positron Emission Tomography) ...
Biology Products: